Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RXST
#2807
RxSight, Inc. Common Stock
7.4
8
-1.97%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.97%
Monatliche Änderung
-18.96%
6 month change
-14.32%
Jahresänderung
-73.75%
Vorheriger Schlusskurs
7.6
3
Open
7.4
8
Bid
Ask
Low
7.4
8
High
7.4
8
Volumen
65
Märkte
Aktien
Gesundheitswesen
RXST
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
27.42 M
33.78 M
36.99 M
40.49 M
41.27 M
—
Valuation ratios
Enterprise value
284.09 M
419.82 M
1.35 B
1.38 B
410.05 M
2.24 B
Price to earnings ratio
-3.15
-5.3
-25.99
-48.42
-10.97
-76.02
Price to sales ratio
6.78
7.21
14.18
9.55
3.17
15.81
Price to cash flow ratio
-3.43
-6.01
-30.36
-78.85
27.44
-83.44
Price to book ratio
1.11
3.93
7.87
4.75
1.54
3.21
Enterprise value to EBITDA ratio
-5.82
-7.06
-29.25
-41.28
-9.12
-59.22
Profitability ratios
Return on assets %
0.25
0.44
0.27
0.09
0.12
0.13
Return on equity %
0.35
0.74
0.3
0.1
0.14
0.14
Return on invested capital %
884.61
956.41
613.43
318.63
334.43
257.29
Gross margin %
19.99
43.52
60.36
70.71
76.6
306.97
Operating margin %
233.64
129.21
56.23
26.34
35.84
144.7
EBITDA margin %
-216.05
-121.28
-51.65
-23.81
-33.43
-134.98
Net margin %
215.5
136.22
54.57
19.62
28.96
117.07
Liquidity ratios
Quick ratio
15.19
6.95
7.22
10.5
9.75
45.53
Current ratio
15.92
7.81
8.06
11.36
10.95
50.29
Inventory turnover
2.25
2.42
2.19
2.08
1.17
1.24
Asset turnover
0.12
0.29
0.54
0.56
0.43
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.21
0.27
0
—
—
—
Long term debt to total equity ratio
0.29
0.45
0
—
—
—
Per share metrics
Operating cash flow per share
3.28
2.13
1.21
0.44
0.38
0.38
EBIT per share
-3.87
-2.29
-1.45
-0.95
-1.18
-1.18
EBITDA per share
-3.58
-2.15
-1.34
-0.86
-1.1
-1.1
Total debt per share
—
—
—
—
—
—
Cash per share
11.69
3.82
3.69
6.1
5.58
22.38
Net current asset value per share
12.94
4.86
4.89
7.56
7.04
28.05
Tangible book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Working capital per share
12.13
4.24
4.28
6.89
6.39
25.81
Book value per share
10.15
3.25
4.65
7.24
6.75
27.2
Nachrichten
Needham reitera recomendação de compra para RxSight com preço-alvo de US$ 13
Needham reiterates Buy on RxSight stock, keeps $13 target
RxSight, Inc. (RXST) Q4 2025 Earnings Call Transcript
Lucro da Rxsight superou projeções por $0,32; receita supera estimativas
Rxsight earnings beat by $0.32, revenue topped estimates
Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates
Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline
Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline
RxSight stock initiated with Market Perform rating by William Blair
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
Jefferies eleva preço-alvo da RxSight para US$ 11,50